MYLAN 2020 MYLAN 2020 (Piroxicam 20 mg)
Pill imprint MYLAN 2020 MYLAN 2020 has been identified as Piroxicam 20 mg.
Piroxicam is used in the treatment of osteoarthritis; temporomandibular joint disorder; rheumatoid arthritis; pain; frozen shoulder and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Piroxicam 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 2020 MYLAN 2020 (Piroxicam 20 mg)
- 20 mg
- 16.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|51079-0743||UDL Laboratories Inc|
|68115-0282||Dispensexpress Inc (repackager)|
|49999-0074||Lake Erie Medical and Surgical Supply (repackager)|
|66267-0168||Nucare Pharmaceuticals Inc (repackager)|
|21695-0285||Rebel Distributors Corp (repackager)|
|16590-0188||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
Piroxicam is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...